期刊文献+

p53,p21/WAF1,pRb的表达与T_1G_3膀胱癌预后的关系 被引量:6

Expressions of p53, p21/WAF1 and pRb in the prognosis of T_1G_3 bladder cancer
原文传递
导出
摘要 目的 探讨p5 3,p2 1/WAF1和pRb的异常表达在T1G3 膀胱癌预后判断中的价值。 方法 对 4 7例T1G3 膀胱癌患者进行术后随访 ,采用p5 3,p2 1/WAF1和pRb单克隆抗体对手术标本行免疫组化染色。将肿瘤进展情况与染色结果和与预后相关的临床指标进行分析。 结果  39例手术保留膀胱的患者总进展率为 5 9% ,其中 9例发生远处转移。 8例行膀胱全切术的患者 1例于术后 2年发现肺转移。肿瘤细胞核p5 3,p2 1/WAF1和pRb蛋白的异常表达率分别为 6 6 .7%、5 1.4 %和 71.8%。多因素分析显示 ,p5 3、pRb同时异常表达 (P <0 .0 5 )和p5 3、p2 1/WAF1、pRb三者同时异常表达(P <0 .0 1)与肿瘤进展显著相关。 结论 p5 3,p2 1/WAF1和pRb的表达与T1G3 Objective To evaluate the prognostic significance of p53, p21/WAF1 and pRb in T 1G 3 transitional cell carcinoma (TCC) of the urinary bladder. Methods Paraffin embedded sections from 47 patients with T 1G 3 TCC of the bladder were studied by immunohistochemistry, using monoclonal antibodies of p53, p21/WAF1 and pRb. The immunostaining results were analyzed in relation to the tumor progression, and compared with the clinical parameters on prognostic significance. Results Of the 39 patients treated by TURBT or partial cystectomy, the total progression rate of the tumor has been 59%.Of the 8 patients treated by cystectomy,one had pulmonary metastasis 2 years after the operation.The abnormal expression rates of p53, p21/WAF1 and pRb were 66.7%, 51.4% and 71.8% respectively. Multivariate analysis indicated that only the combined abnormal expressions of p53, p21/WAF1 and pRb provided prognostic information in T 1G 3 TCC of the bladder. Conclusions Immunohistochemical evaluation of p53, p21/WAF1 and pRb nuclear expressions would help the prognostic evaluation cases of T 1G 3 TCC of the bladder.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2002年第9期562-564,共3页 Chinese Journal of Urology
关键词 P53 P21/WAF1 PRB 基因表达 免疫组织化学染色 T1G3膀胱癌 预后 Bladder neoplasms Prognosis Genes
  • 相关文献

参考文献1

  • 1陈戈明 蔡松良 等.膀胱癌中抑癌基因p53、Rb、p16及p15表达的研究[J].中华泌尿外科杂志,2000,12:737-737.

共引文献1

同被引文献49

  • 1申文江.膀胱癌辅助治疗进展[J].中国处方药,2004(12):44-48. 被引量:2
  • 2侯宇.抑癌基因新发现和致癌机制新观点[J].国外医学(肿瘤学分册),1995,22(2):65-68. 被引量:13
  • 3滕晓东.P53与P21基因蛋白在脑星形细胞瘤的表达[J].南通医学院学报,1996,16(2):167-168. 被引量:1
  • 4Sakitani H, Tsujiuchia T, Kobitsub K. Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats[J]. Cancer Lett, 1998, 126:157-164.
  • 5Banerji A, Femandes A, Bane S. Treatment with field bean protease inhibitor can effectively repress ethylnitrosourea (ENU)-induced neoplasms of the nervous system in Sprague-Dawley rats [J].Cancer Lett, 1998, 130:161-167.
  • 6Mendoza MA. P21 WAF1/CIP1 inhibits cell cycle progression but not G2/M-Phase transition following methylmercury exposure[J]. Toxicol Appl Pharmacol,2002, 178:117-125.
  • 7Swanson SM. N-ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-metyl-N-nitrosourea[J]. Cancer Lett,1996, 102:159-165.
  • 8Donovan AJ. Cell sensitivity to transplacental carcinogenesis by N-ethyl-N-nitrosourea is greatest in early post-implantation development[J]. Murat Res, 1999, 427:47-51.
  • 9Li Su. P53(codon 72)and p21 (codon 31) polymorphisms alter in vivo mRNA expression of P21 [J]. Lung Cancer, 2003, 40:259-266.
  • 10Ding H. P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells [J]. Biochem Biophys Res Communi, 2003, 305 : 950-956.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部